🚀 ProPicks AI Hits +34.9% Return!Read Now

CNBC's Final Trades: Sabra Health Care, Eli Lilly, FedEx And This Way To Gain EV Exposure

Published 10/06/2022, 13:30
Updated 10/06/2022, 14:10
© Reuters.  CNBC's Final Trades: Sabra Health Care, Eli Lilly, FedEx And This Way To Gain EV Exposure
FDX
-
LLY
-
SBRA
-
FDXB34
-

On CNBC’s “Halftime Report Final Trades,” Jenny Harrington of Gilman Hill Asset Management said Sabra Health Care REIT Inc (NYSE:WELL) (NASDAQ: SBRA) has an 8.5% yield and “a really terrific management team.” She added, “I think they’re just getting back on stable footing. So, now is the time to buy it.”

Rob Sechan of New Edge Capital Group said Eli Lilly (NYSE:LLY) and Co’s (NYSE: LLY) fundamentals are “great” and that the company has “low debt, high cash, 30% operating margins, healthy free cash flow.” He added that the company is “best in class” and that “it’s going to be a great stock.”

Check out other stocks making big moves in the premarket.

Stephen Weiss of Short Hills Capital Partners said he was staying in cash but “if the market really sells off tomorrow,” he would buy FedEx Corporation (NYSE: NYSE:FDX).

Joshua Brown of Ritholtz Wealth Management mentioned that ChargePoint Holdings Inc (NYSE: CHPT) had a huge rally on a big deal with the National Electricians Union and has been flat after that. “That’s very positive,” he added.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.